Published in Curr Opin Biotechnol on August 01, 1997
Conformations of immunoglobulin hypervariable regions. Nature (1990) 5.31
Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. J Mol Biol (1986) 4.16
The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A (1974) 3.92
Antibody-antigen complexes. Annu Rev Biochem (1990) 3.91
Three-dimensional structure of the tryptophan synthase alpha 2 beta 2 multienzyme complex from Salmonella typhimurium. J Biol Chem (1988) 3.52
Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci U S A (1987) 3.48
Three-dimensional structure of immunoglobulins. Annu Rev Biochem (1975) 1.99
Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. Proc Natl Acad Sci U S A (1987) 1.82
Antibody-antigen complexes. J Biol Chem (1988) 1.69
Structural basis for the specificity of phosphorylcholine-binding immunoglobulins. Immunochemistry (1976) 1.63
Structure at 4.5 A resolution of a phosphorylcholine-binding fab. Nat New Biol (1973) 1.60
Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315. Cold Spring Harb Symp Quant Biol (1977) 1.54
Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex. J Exp Med (1992) 1.43
Structure and refinement at 1.8 A resolution of the aspartic proteinase from Rhizopus chinensis. J Mol Biol (1987) 1.43
Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis. Proc Natl Acad Sci U S A (1972) 1.34
Refined crystal structure of deoxyhemoglobin S. II. Molecular interactions in the crystal. J Biol Chem (1985) 1.22
Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE. Eur J Immunol (1996) 1.20
Structural basis for the specificity of antibody-antigen reactions and structural mechanisms for the diversification of antigen-binding specificities. Q Rev Biophys (1977) 1.19
H-2Dd exploits a four residue peptide binding motif. J Exp Med (1993) 1.13
Refined crystal structure of deoxyhemoglobin S. I. Restrained least-squares refinement at 3.0-A resolution. J Biol Chem (1985) 1.12
A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties. AIDS Res Hum Retroviruses (1997) 1.10
The structural and genetic basis for expression of normal and latent VHa allotypes of the rabbit. Mol Immunol (1984) 1.10
Variability of three-dimensional structure in immunoglobulins. Proc Natl Acad Sci U S A (1975) 1.09
On the specificity of antibody/antigen interactions: phosphocholine binding to McPC603 and the correlation of three-dimensional structure and sequence data. Ann Inst Pasteur Immunol (1985) 1.08
Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA. Eur J Immunol (2000) 1.06
Three-dimensional structure of hemoglobin from the polychaete annelid, Glycera dibranchiata, at 2.5 A resolution. J Biol Chem (1974) 1.05
A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2. J Immunol (1995) 1.00
An em study of phosphorylcholine-binding fab immunoglobulin fragment crystals. J Ultrastruct Res (1975) 0.98
Crystalline monoclonal antibody Fabs complexed to hen egg white lysozyme. J Mol Biol (1984) 0.98
Structural implications of sequence variability in immunoglobulins. Proc Natl Acad Sci U S A (1977) 0.93
Inhibition of mast cell sensitization in vitro by a human immunoglobulin epsilon-chain fragment synthesized in Escherichia coli. Eur J Immunol (1985) 0.93
Crystal structure of galactan-binding mouse immunoglobulin J539 Fab at 4.5-A resolution. Proc Natl Acad Sci U S A (1979) 0.89
Structural studies of human autoantibodies. Crystal structure of a thyroid peroxidase autoantibody Fab. J Biol Chem (1996) 0.88
Immunoglobulin structures at high resolution. Contemp Top Mol Immunol (1975) 0.88
A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23). J Immunol (1988) 0.87
Structural and genetic basis of idiotypy in the galactan-binding myeloma proteins. Ann Immunol (Paris) (1979) 0.87
Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors. Proteins (1992) 0.87
Binding characteristics of IgA 16.4.12E, a monoclonal antibody with specificity for the nonreducing terminal epitope of alpha-(1----6)-dextrans. Comparisons between IgA hybridoma 16.4.12E and myeloma W3129. J Biol Chem (1990) 0.87
Generation and characterization of a novel single-gene-encoded single-chain immunoglobulin molecule with antigen binding activity and effector functions. Mol Immunol (1999) 0.86
Evolutionary and structural influences on light chain constant (CL) region of human and mouse immunoglobulins. Proc Natl Acad Sci U S A (1975) 0.86
Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules. EXS (1995) 0.85
A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation. Int Immunopharmacol (2001) 0.85
Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49. Hybridoma (1995) 0.84
A humanized antibody with specificity for hepatitis B surface antigen. Hum Antibodies Hybridomas (1996) 0.84
Twisting into shape. Curr Biol (1992) 0.83
Amino acid residues that influence Fc epsilon RI-mediated effector functions of human immunoglobulin E. Biochemistry (1998) 0.83
Evaluation of the structural variation among light chain variable domains. Mol Immunol (1979) 0.83
Modeling of antibody combining sites. Methods Enzymol (1991) 0.82
Modeling of the lectin-homology domains of the human and murine low-affinity Fc epsilon receptor (Fc epsilon RII/CD23). Receptor (1993) 0.81
A model of the Fc of immunoglobulin E. Mol Immunol (1986) 0.80
Defective protein phosphorylation and Ca2+ mobilization in a low secreting variant of the rat basophilic leukemia cell line. J Biol Chem (1994) 0.80
Identification of the high affinity receptor binding region in human immunoglobulin E. J Biol Chem (1996) 0.80
A T cell receptor V alpha domain expressed in bacteria: does it dimerize in solution? J Exp Med (1996) 0.80
A crystallographic study of deoxy cobalt (II) mesoporphyrin IX myoglobin. J Biol Chem (1975) 0.80
CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity. Mol Immunol (2000) 0.79
A modeling study of the alpha-subunit of human high-affinity receptor for immunoglobulin-E. Receptor (1992) 0.79
Crystalline semisynthetic ribonuclease-S'. Proc Natl Acad Sci U S A (1976) 0.79
Development of a minimally immunogenic variant of humanized anti-carcinoma monoclonal antibody CC49. Crit Rev Oncol Hematol (2001) 0.79
Generation and characterization of a single gene-encoded single-chain-tetravalent antitumor antibody. Clin Cancer Res (1999) 0.79
Human IgE mediates stimulus secretion coupling in rat basophilic leukemia cells transfected with the alpha chain of the human high-affinity receptor. Eur J Immunol (1993) 0.78
Glycera dibranchiata hemoglobin. X-ray structure of carbonmonoxide hemoglobin at 1.5 A resolution. J Mol Biol (1994) 0.78
Localization of rabbit kappa light chain allotypic determinants. Mol Immunol (1986) 0.78
The nature and importance of the inter-epsilon chain disulfide bonds in human IgE. Eur J Immunol (1991) 0.78
Two Ig framework I epitopic specificities recognized by a rabbit antiserum and a monoclonal antibody to mouse VH chains. J Immunol (1990) 0.77
Structural significance of sequence variability in antibody complementarity-determining regions. Res Immunol (1994) 0.77
Structure of the haemoglobin of the marine annelid worm, Glycera dibranchiata, at 5.5 A resolution. Nature (1968) 0.77
Crystallographic studies and primary structure of the antitumor monoclonal CC49 Fab'. Proteins (1993) 0.77
Quantitation of the immunogenic potential of protein antigens. Mol Immunol (1985) 0.77
The X-ray crystal structure of a Valpha2.6Jalpha38 mouse T cell receptor domain at 2.5 A resolution: alternate modes of dimerization and crystal packing. J Mol Biol (1999) 0.77
Binding of modified fragments of the Shigella dysenteriae type 1 O-specific polysaccharide to monoclonal IgM 3707 E9 and docking of the immunodeterminant to its modeled Fv. Carbohydr Res (1998) 0.76
Structure-function studies of anti-3-fucosyllactosamine (Le(x)) and galactosylgloboside antibodies. J Immunol (1994) 0.76
Structure-function studies of an anti-asialo GM1 antibody obtained from a phage display library. J Neuroimmunol (1999) 0.76
Why don't humans get scrapie from eating sheep? A possible explanation based on secondary structure predictions. Med Hypotheses (2005) 0.76
Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38. Proc Natl Acad Sci U S A (1994) 0.76
The codon for the methionine at position 129 (M129) in the human prion protein provides an alternative initiation site for translation and renders individuals homozygous for M129 more susceptible to prion disease. Med Hypotheses (2005) 0.76
Peptide blocking of IgE/receptor interaction: possibilities and pitfalls. Allergy (1997) 0.75
Commerce versus collaboration. Lancet (1991) 0.75
Development of more efficacious antibodies for medical therapy and diagnosis. Prog Nucleic Acid Res Mol Biol (1998) 0.75
Humanization of KC4G3, an anti-human carcinoma antibody. Hybridoma (1994) 0.75
The effect of insulinomimetic agents on protein degradation in H35 hepatoma cells. Mol Cell Biochem (1986) 0.75
Structure of a phosphorycholine-binding mouse myeloma Fab. Transplant Proc (1975) 0.75
Antibody Fab assembly: the interface residues between CH1 and CL. Mol Immunol (1986) 0.75
Effect of monoclonal antihuman IgE on recombinant IgE(301-376) inhibition of specific IgE histamine release. Int Arch Allergy Appl Immunol (1989) 0.75
Modelling study of IgE/receptor interactions. Biochem Soc Trans (1993) 0.75
Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3. Adv Exp Med Biol (1994) 0.75
Immunological effects of grain dust. Biochem Soc Trans (1997) 0.75
Structure/function studies on IgE as a basis for the development of rational IgE antagonists. Allergy (1998) 0.75
Characterization of defective phorbol ester responses in a low secreting rat basophilic leukemia (RBL-2H3) cell variant. Receptor (1993) 0.75
The structures of lamprey and bloodworm hemoglobins in relation to their evolution and function. Cold Spring Harb Symp Quant Biol (1972) 0.75
Are humans getting 'mad-cow disease' from eating beef, or something else? Med Hypotheses (2003) 0.75
Recombinant human IgE. Int Arch Allergy Appl Immunol (1987) 0.75
Does mRNA translation starting from an alternative initiation site contribute to the pathology of Huntington's disease? Med Hypotheses (2000) 0.75
The isoelectric points of cytochromes in the reduced and oxidised forms. Comp Biochem Physiol B (1982) 0.75
The structural basis of human IgE-Fc receptor interactions. Clin Exp Allergy (1999) 0.75
Molecular-replacement structure determination of two different antibody:antigen complexes. Acta Crystallogr B (1990) 0.75
Protein and cell engineering of components of the human immunoglobulin E receptor/effector system: applications for therapy and diagnosis. Technol Health Care (1998) 0.75
Protein mapping in rat basophilic leukaemia cells. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.75